FCI EXCLUSIVE

Precivia® simplifies* intravitreal injections by making the procedure faster and more predictable*. Its unique design presents a guide tube accurately oriented to ensure a fixed injection angle of 28°, a fixed distance at 3.5 mm from the limbus, and a controlled depth.

Precivia® ensures a safer injection procedure that eliminates the need of speculum, caliper or pressure plate.

After preparing the patient for the procedure, Precivia® is carefully placed on the patient's eye with the positioning line on the limbus. By gently pushing down and rotating the Precivia® device, the eye is stabilized so the patient feels an anesthetic effect due to the pressure, and cannot see the needle coming. After removing the needle, a rotation post-injection replaces the conjunctiva and seals the injection hole.

Main characteristics:

• Eliminates unnecessary instruments
• Assures accuracy
• Relaxes patients*
• Prevents leakage*
• Compatible with popular anti-VEGF drugs
• Sterile, Single use
• Box of 25

_{*References: Ratnarajan G, Nath R, Appaswamy S, et al. Intravitreal injections using a novel conjunctival mould: a comparison with a conventional technique. British Journal of Ophthalmology 2013;97:395-397. Petri, A., Boysen, K., Cehofski, L.J. et al. Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach. Ophthalmol Ther 9, 191–203 (2020).}

_{Precivia® is a Class Is medical device indicated for intravitreal injections and manufactured by FCI S.A.S. - Notified Body: GMED CE n°0459.}